Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by repetitive behaviors in addition to cognitive and social skills deficits—both verbal and non-verbal (Gyawali & Patra,
2019). The worldwide prevalence of ASD is estimated at around 1%, although this percentage is considered to be higher in developed countries. Furthermore, it is also known that this disorder seems to affect boys more than girls (Lai et al.,
2014; Lord et al.,
2020). The causes of this disorder are still unknown. However, in the current literature, there is a general consensus that the etiology of this disorder is multifactorial, including genetic or environmental factors (Schaaf et al.,
2020). Regarding these lasts, exposure to pesticides, and more concretely, prenatal exposure to Chlorpyrifos (CPF), an organophosphate (OPs), has been considered as a possible contributing element in the development of autism (Persico & Merelli,
2014).
The main mechanism of action of CPF is the inhibition of acetylcholinesterase (AChE), which causes overstimulation of cholinergic receptors, leading to collapses within the nervous system (US Department of Health & Human Services,
1997). During prenatal development, CPF exposure at toxic doses ranges from disruption of cell proliferation, differentiation, and apoptosis (Raszewski et al.,
2015) to impaired dendritic maturation (Howard et al.,
2005).
In humans, according to a study conducted in California, the risk of presenting ASD was twice as high for those children born from mothers who, during gestation, were exposed to pesticides (among them CPF) due to their proximity to crop fields (Shelton et al.,
2014). This data is supported by other studies that showed abnormalities in the brains of children who had been prenatally exposed to CPF, finding that these children also obtained lower scores on intelligence tests. In addition, such a link to pesticide exposure has also been reported in autistic children (Gunier et al.,
2017; Rauh et al.,
2012).
In rodent research in which the control of intervening variables is more precise, it has been shown how prenatal exposure to CPF, at doses that do not cause AChE inhibition, results in impairments similar to those observed in ASD. These impairments include decreased social behaviors (Lan et al.,
2017) reduction in the number and length of ultrasonic vocalizations emitted (Venerosi et al.,
2009), and even hyperactive behaviors (Grabovska & Salyha,
2015), something that has been associated (due to high comorbidity rates) with ASD (Sokolova et al.,
2017).
However, despite these data, it is not entirely clear whether prenatal exposure to CPF is related to ASD (Biosca-Brull et al.,
2021; Williams & Desesso,
2014). Thus, to go a step further in this regard, it is useful to employ an accepted autistic animal model, such as valproic acid (VPA; Ergaz et al.,
2016; Mabunga et al.,
2015). This model of ASD has been confirmed by studies carried out using rats and mice since, after prenatal exposure to the drug, they show characteristics very similar to those expected in individuals with ASD (Chaliha et al.,
2020; Mabunga et al.,
2015). These features include a reduction in the production of ultrasonic calls in isolated pups (Cezar et al.,
2018; Dai et al.,
2018; Morales-Navas et al.,
2020), increased levels of anxiety and stereotypical behaviors (Bronzuoli et al.,
2018; Servadio et al.,
2015) and deficits in social interactions in the 3-chambered test (Bambini-Junior et al.,
2014; Bronzuoli et al.,
2018; Kim et al.,
2014).
In addition, there are also significant similarities between the neurobiological effects of prenatal exposure to VPA and CPF. For example, GABAergic alterations have been observed in animals exposed perinatally to subclinical doses of CPF, which do not irreversibly inhibit AChE (Perez-Fernandez et al.,
2020b), and in animals treated prenatally with VPA (Hou et al.,
2018; Wei et al.,
2016). In fact, metabolomics analyses of prenatal administration of CPF and VPA pointed out an alteration in the cerebral levels of glutamine, GABA, and choline (Abreu et al.,
2021). This is very important if we consider that the GABA dysfunctions appear to play in the brain's excitatory/inhibitory electrophysiological balances and also the suggested role of the alterations in the cholinergic system in the etiology of ASD (Gogolla et al.,
2009; Wang et al.,
2015; Ford & Crewther,
2016; Hou et al.,
2018).
Given the above considerations, the present study set out to conduct, for the first time, a direct comparison between the social interaction of rats prenatally exposed to subclinical doses of CPF and those exposed to VPA within the same period of fetal development. To this end, two experiments were conducted to evaluate social behavior using the 3-chambered test in different groups of rats (from the same litters): one in adolescence and the other in adulthood.
Methods
Experimental Animals
The mothers were twenty-five 3-month-old pregnant Wistar rats (Janvier Labs; Le Genest-Saint-Isle, France) housed individually in transparent polycarbonate cages (50 × 15 × 24 cm) in our Facility. For 6 days, the rats were acclimatized to their new environment, regulated at a temperature of 22 ± 2 °C and humidity at 50 ± 10%. The light/dark cycle was reversed, with lights on from 19:00 to 07:00 h. All rats gave birth on the expected day, postnatal day 0 (PND0).
On the following day (PND1), all pups were separated from their mothers to be randomly distributed among them, keeping a ratio of five females and five males per mother to minimize differences in rearing. Making a total of 10 pups per mother, among which a balanced number of 3 ± 1 pups per experimental group was maintained. The mothers had continuous free access to water and food. Furthermore, the offspring were weighed regularly to monitor possible signs of intoxication. We started with this last routine at PND10 as we wanted to prevent extreme maternal reactions that could affect the offspring. This study is part of the project PSI2017-86847-C2-1-R and was conducted following the Royal Decree 53/2013 and the European Community Directive (2010/63/EU) for Animal Research and approved by the Animal Research Committee of the University of Almeria (29/05/2020/067).
Administration Protocol
On Gestation day (GD) 11, the mothers were randomly assigned to one of the following three experimental groups: control group (CNT), chlorpyrifos group (CPF), and valproic acid group (VPA). Then, at GD 12.5, all pregnant mothers started treatment according to the following protocol:
CNT (n = 8) a subcutaneous injection of 1 mL/kg dimethyl sulfoxide (DMSO) for 4 days (vehicle).
CPF (n = 8) a subcutaneous injection of 1 mg/kg of CPF [O, O-diethyl O-3, 5, 6-trichloropyridin-2-yl phosphorothioate (Pestanal, Sigma Aldrich)] dissolved in DMSO (100 mg/mL) for 4 days.
VPA (
n =
9) one subcutaneous injection of 400 mg/kg of VPA (to avoid possible maternal death Vorhees,
1987), dissolved in 0.9% saline at a concentration of 250 mg/mL, and three daily subcutaneous injections with only saline solution.
Pregnant mothers were weighed daily to ensure that the correct doses were administered.
The schedule of administrations was completed at GD 15.5 when all mothers had received four subcutaneous injections each (Table
1).
Table 1
Schedule of doses
Control | DMSO | DMSO | DMSO | DMSO |
CPF | CPF | CPF | CPF | CPF |
VPA | VPA | Saline | Saline | Saline |
Sociability Test
The apparatus consists of a rectangular box (96 × 105 cm) based on that designed by Crawley (
2004, which has three different chambers (96 × 35 cm): one in the center and two on both sides. The chambers are separated by glass to allow the animal to see from the exit chamber (the central one) what is in the other two. The side chambers were virtually divided into:
All the animals that passed the test explored the apparatus the day before for 10 min to avoid novel behavior that could interfere with the measurements. The experiments were carried out between 8:00 and 14:00 h. The test consisted of three consecutive phases, all lasting 10 min. After each animal had been tested, the apparatus was cleaned with a 70% alcohol solution.
-
Session 1: acclimatization of the animal. During this session, the animal was allowed to explore only and exclusively the central chamber, with access to the two other chambers closed. This session was used to measure the locomotor activity of the subjects. After 10 min, the subjects were momentarily removed from the apparatus before moving on to the next phase.
-
Session 2: sociability. In this session, the animal's social behavior was measured by placing a congener in one of the lateral chambers. This congener (Stranger 1) was enclosed in a metal cage that allowed, if necessary, contact between the subjects. In this phase, the time spent in each chamber and the contact time with the congener were measured, as well as the Sociability Index (calculated with the time spent in each chamber) and the Sociability Contact Index (calculated with the time spent inside the perimeters near the cages where the congeners were placed). In addition, the latencies of the first entry to each chamber were also measured, as well as the number of entries to the contact zone. Before the next test, the subject was momentarily removed from the apparatus.
-
Session 3: reaction to social novelty. During this phase, the response to social novelty shown by the subjects was evaluated. Thus, in this phase, in addition to the now known congener (Familiar), a new individual (Stranger 2) was placed in the cage of the other chamber. The time spent in each chamber and inside of the contact zone with each individual was then measured, as well as the Social Novelty Reaction Index (calculated with the time in each chamber) and the Social Novelty Contact Reaction (calculated with the time spent within the perimeters near the cages where the conspecifics were placed). In addition, the latencies of the first entry to each chamber were measured again, as well as the number of entries to the contact zone.
The animals were tracked using Ethovision 3.1, with an overhead camera as input. The light was subtly arranged so as not to disturb the animals.
The groups of animals that were part of the two experiments were:
-
In adolescence [postnatal day 37–46; (PND 37–46)] 20 CNT (10 females and 10 males), 21 CPF (11 females and 10 males), and 20 VPA (10 females and 10 males).
-
In adulthood (PND 180–189) 20 CNT (10 females and 10 males), 21 CPF (10 females and 11 males), and 20 VPA (10 females and 10 males).
Statistical Analysis
The statistical analyses used for the 3-room test were ANOVA for parametric data and the Holm–Sidak multiple comparisons test for post hoc data, while the non-parametric data were analyzed using Friedman's statistic and the Kruskal–Wallis analysis of variance. For multiple comparisons, within these non-parametric analyses, Dunn's multiple comparisons were used. Finally, when the analyses consisted of only two groups, the Student's t-test was used for parametric analyses and the Wilcoxon test for non-parametric analyses.
The following formulas were used to measure the indices of sociability and reaction to social novelty (Bambini-Junior et al.,
2014; Kim et al.,
2014):
Phase 2—Sociability$$Sociability\, Index= \frac{time\, with\, Stranger\, 1- time \,in \,empty\, compartment}{ time\, with \,Stranger\, 1+time\, in\, empty\, compartment},$$
$$Sociability\, Index{\text{-}}Contact= \frac{time\, in\, the\, perimeter\, closest \,to\, Stranger\, 1- time \,in\, the\, perimeter\, closest\, to\, the\, empty \,compartment}{ time\, in\, the\, perimeter \,closest\, to\, Stranger\, 1+time \,in\, the\, perimeter \,closest\, to\, the\, empty \,compartment}.$$
Phase 3—Reaction to Social Novelty
$$Social\, Novelty \,Index= \frac{time\, with \,Stranger\, 2-time\, with\, family\, member}{ time\, with\, Stranger\, 2+time\, with\, a \,family\, member},$$
$$Social \,Novelty\, Index{\text{-}}Contact= \frac{time \,in \,the\, perimeter\, closest\, to\, Stranger\, 2- time\, in\, the\, perimeter\, closest\, to\, the\, family \,member}{ time \,in \,the\, perimeter\, closest \,to \,Stranger\, 2+ time\, in\, the\, perimeter\, closest\, to \,the\, family\, member}.$$
Based on the assessments of Bambini-Junior et al. (
2014), those subjects who did not spend time with the previous congener in Phase 2 and those who did not visit the three chambers in Phase 3 were eliminated.
All analyses were conducted using GraphPad Prism 8.0 software (San Diego, CA, USA).
Discussion
In this study, we aimed to explore potential similarities between animals prenatally exposed to VPA and CPF, using, in this latter, subclinical doses routinely found in fetal brains (Gu et al.,
2020) in an administration window equivalent to the first trimester of human fetal development. This time window is frequently used in the VPA animal model of autism (Bambini-Junior et al.,
2014; Chaliha et al.,
2020; Mabunga et al.,
2015; Ross et al.,
2015; Schneider & Przewłocki,
2005). The data presented in this study are novel since, to our knowledge, no study in the current literature has compared rats exposed to these two compounds at two points of development such as adolescence and adulthood.
Considering the possibility of the prenatal effects of CPF and VPA during development, the animals were weighed during their first stage of development, and no alteration was found. In addition, the expression of AChE activity was measured in these groups, and no significant differences were found between them (Morales-Navas et al.,
2020).
For adolescent behavior, in Phase 1, we have found that the CPFs show less locomotor activity than the rest of the groups. Although the opposite it was expected due to the comorbidity between ADHD and ASD is high (Antshel et al.,
2013; Sokolova et al.,
2017). However, ASD appears to have a very complex etiology, with many different factors, so this comorbidity is not total.
Concerning the sociability shown by the adolescent subjects (Phase 2), although there are within-group differences, we did not find any significant differences between groups using the sociability index. This result in VPA is in line with another investigation that used a dose identical to ours (Bambini-Junior et al.,
2014). Thus, they are showing a behavior within our hypothesis expectations.
In Phase 3, relating to the reaction to the social novelty of adolescents, we observed clearly how CPFs and VPAs behave almost identically in comparison to CNTs. This is further supported by the difference we found in the reaction to social novelty indexes. More specifically, for the perimeter of the entire habitat (SNI), the CPF rats differed significantly from the CNT group but not the VPAs, which appear to be very similar to the CPFs. This data obtained with VPA has been observed in other studies, such as that of Kim et al. (
2014), in which an equivalent dose was used. Other similar experiments using CPFs, such as that of Venerosi et al. (
2008) or Perez-Fernandez and et al. (
2020a,
b), did not show any difference in this phase, possibly because none of these studies used prenatal doses.
Turning to the results found for adults with the 3-chambered paradigm, a somewhat different picture emerges. In Phase 1, the differences between the CPF and the other two groups completely disappear, which may be directly due to the passage of time since it is known that adolescent rats are more active (Spear,
2000).
In the social phase, CNTs and CPFs exhibited similar behavior, while VPAs didn't show a clear preference for Stranger 1. These findings are supported by the sociability indexes, both in the SI and the SNI-Contact (the latter shows stability in the data). The difference was between the CPFs and the VPAs, with the CNTs remaining as an intermediate group. This change could be because the systemic damage caused by VPA could be more severe and sustained over time compared to that caused by CPF. It is important to remember that VPA is a widely accepted model of autism in the scientific community, while the CPF has received more criticism in this regard (Williams & Desesso,
2014).
In the reaction to the social novelty phase, CPFs and VPAs displayed a preference for the new conspecific, something that surprisingly did not occur with the CNT group, which was expected to spend more time with Stranger 2 (Crawley,
2004; Moy et al.,
2004). What could be happening in this case is a bidirectional effect. While VPA-exposed animals benefit from being raised alongside non-autistic animals and environmental enrichment (Campolongo et al.,
2018; Schneider et al.,
2006; Yamaguchi et al.,
2017), CNT animals are also influenced by the VPAs. In between would be the CPF animals, representing a much “weaker” version of certain autistic characteristics, and therefore, subject to a more noticeable improvement in the social aspects. However, this possibility is merely speculative and should be tested with further research.
On the basis of this study, it seems that animals prenatally exposed to subclinical doses of CPF at days 12.5–15.5 show certain social characteristics similar to those observed in animals exposed to VPA, which shifts from a decline in adolescence (this alteration being more pronounced than that shown by VPA animals), to a recovery in adulthood. This finding could be due to co-breeding with CNT congeners and environmental enrichment. The stability found in VPA animals—the positive control model—could mean that there are more difficulties in recovering them by mere upbringing or a later life shared with other congeners who do not present the same disorder.
Thus, given all the above, and with the knowledge that more research is needed, CPF is a compound that should be considered as a risk factor in the development (either as an aggravator or elicitor) of certain dysfunctions related to the etiology of ASD.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
All the data associated to this research are available in:
Morales-Navas, M., Castaño-Castaño, S., Pérez-Fernández, C., Sánchez-Gil, A., Teresa Colomina, A., Leinekugel, X., and Sánchez-Santed, F. Data Repository. Science Data Bank. DOI:
https://doi.org/10.57760/sciencedb.07543